Mid-infrared Wearable for Non-invasive biomarker monitoring
The project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management.
Projectdetails
Introduction
Modern medicine has improved dramatically through a better understanding of what causes a condition or what it is correlated to. However, the healthcare system still follows an episodic (reactive) model, where patients only seek medical advice when there are symptoms. This approach has proven critically insufficient for certain medical conditions.
Background
In this context, one of the main burdens for our socioeconomic system in Europe caused by a single disease is undoubtedly the metabolic syndrome (MbS). MbS is prominently visible in the large and ever-growing number of overweight or obese individuals.
Consequences of Metabolic Syndrome
The true negative dramatic consequences of MbS include:
- Arteriosclerosis
- Myocardial infarction
- Stroke
Several biomarkers such as uric acid, albumin, or ketone bodies correlate with MbS and often indicate different aspects of the metabolic syndrome. The more biomarkers that can be measured and quantified with high accuracy, the easier it becomes to make conclusive decisions on the patient’s status.
Importance of Accurate Measurement
False negatives as well as false positives can be avoided much better with more parameters, provided that each of them is measured individually and directly. This eliminates the need for indirect methods where evaluations are easily overfitted.
Project Overview
We provide an alternative approach for the measurement of biomarkers, using a miniaturized Mid-Infrared spectrometer, a technology that is currently only used in laboratories due to its size and cost.
Project Outcome
The result of the project will be a wearable device designed to detect biomarkers non-invasively and pain-free in the interstitial fluid in the skin.
Consortium and Engagement
For MiWear, we have gathered an impressive consortium that combines expert knowledge in various fields, including:
- Biomarkers
- Optical spectroscopy
- Laser physics
- Business management
- Finances
- The gender dimension of biomarkers
During the project, we will generate opportunities for young researchers and engage with different stakeholders to ensure maximum outreach of our research and development activities.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.991.297 |
Totale projectbegroting | € 3.991.297 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2026 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- QUANTUNE TECHNOLOGIES GMBHpenvoerder
- JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH
- STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
- TEKNOLOGIAN TUTKIMUSKESKUS VTT OY
- ARTIFICIAL INTELLIGENCE EXPERT SRL
- SCIENCE&STRATEGY SL
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
Dynamic Spatio-Temporal Modulation of Light by Phononic ArchitecturesDynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements. | EIC Pathfinder | € 2.552.277 | 2022 | Details |
Emerging technologies for crystal-based gamma-ray light sourcesTECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology. | EIC Pathfinder | € 2.643.187 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures
Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.
Emerging technologies for crystal-based gamma-ray light sources
TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Miniaturized flexible batteries for next generation wearable healthcare sensorsFlexiMin aims to develop a flexible, miniaturized battery to power next-gen wearable sensors for continuous biomarker monitoring, enhancing healthcare diagnostics and market readiness. | ERC POC | € 150.000 | 2025 | Details |
Geautomatiseerde bloeddrukmetingHet project onderzoekt de haalbaarheid van continue bloeddrukmeting met innovatieve micro-wearables om hypertensie beter te diagnosticeren en zorgkosten te verlagen. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
Accurater metabolisme meetinstrumentHet project ontwikkelt een modulair ademgasanalysesysteem voor (top)sport en medische diagnostiek, gericht op het meten van energieverbruik en -balans met minimale belasting voor gebruikers. | MIT R&D Samenwerking | € 103.748 | 2016 | Details |
Miniaturized flexible batteries for next generation wearable healthcare sensors
FlexiMin aims to develop a flexible, miniaturized battery to power next-gen wearable sensors for continuous biomarker monitoring, enhancing healthcare diagnostics and market readiness.
Geautomatiseerde bloeddrukmeting
Het project onderzoekt de haalbaarheid van continue bloeddrukmeting met innovatieve micro-wearables om hypertensie beter te diagnosticeren en zorgkosten te verlagen.
Accurater metabolisme meetinstrument
Het project ontwikkelt een modulair ademgasanalysesysteem voor (top)sport en medische diagnostiek, gericht op het meten van energieverbruik en -balans met minimale belasting voor gebruikers.